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ABSTRACT: Microbial lanthipeptides are formed by a two-step
enzymatic introduction of (methyl)lanthionine rings. A dehydra-
tase catalyzes the dehydration of serine and threonine residues,
yielding dehydroalanine and dehydrobutyrine, respectively.
Cyclase-catalyzed coupling of the formed dehydroresidues to
cysteines forms (methyl)lanthionine rings in a peptide. Lanthipep-
tide biosynthetic systems allow discovery of target-specific,
lanthionine-stabilized therapeutic peptides. However, the substrate
specificity of existing modification enzymes impose limitations on
installing lanthionines in non-natural substrates. The goal of the
present study was to obtain a lanthipeptide dehydratase with the
capacity to dehydrate substrates that are unsuitable for the nisin
dehydratase NisB. We report high-throughput screening for tailored specificity of intracellular, genetically encoded NisB
dehydratases. The principle is based on the screening of bacterially displayed lanthionine-constrained streptavidin ligands, which
have a much higher affinity for streptavidin than linear ligands. The designed NisC-cyclizable high-affinity ligands can be formed via
mutant NisB-catalyzed dehydration but less effectively via wild-type NisB activity. In Lactococcus lactis, a cell surface display
precursor was designed comprising DSHPQFC. The Asp residue preceding the serine in this sequence disfavors its dehydration by
wild-type NisB. The cell surface display vector was coexpressed with a mutant NisB library and NisTC. Subsequently, mutant NisB-
containing bacteria that display cyclized strep ligands on the cell surface were selected via panning rounds with streptavidin-coupled
magnetic beads. In this way, a NisB variant with a tailored capacity of dehydration was obtained, which was further evaluated with
respect to its capacity to dehydrate nisin mutants. These results demonstrate a powerful method for selecting lanthipeptide
modification enzymes with adapted substrate specificity.
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Lanthipeptides are (methyl)lanthionine ring-containingribosomally synthesized and post-translationally modified
peptides (RiPPs).1 Many natural lanthipeptides show potent
antimicrobial activity against human pathogens and even
against antibiotic-resistant human pathogens. Importantly, the
lantibiotics duramycin and NVB-302 and the lanthipeptide
MOR107 have already been tested in the clinic. The ribosomal
synthesis and enzymatic modifications of lanthipeptides
provide excellent opportunities for the discovery of lanthio-
nine-stabilized and target-specific therapeutic peptides.2−4
The nisin biosynthetic machinery has been well-studied and
is widely used. This system allows us to engineer and
heterologously produce novel lanthipeptides. It comprises the
NisB dehydratase, which is responsible for serine/threonine
dehydration in the core peptide, the NisC cyclase, which
couples the dehydroresidues to cysteines yielding (methyl)-
lanthionine rings, and the transporter NisT, which secretes
modified peptides.5 The peptidase NisP is responsible for
cleaving off the leader peptide, thus yielding mature
lanthipeptides.5 NisB is a fascinating enzyme whose mecha-
nism is glutamyl-tRNAGlu-dependent. The crystal structure of
NisB, in complex with its natural substrate peptide NisA,
reveals two separate domains, one domain that catalyzes the
Ser/Thr glutamylation and another domain that is responsible
for glutamate elimination.6 Its Ser/Thr dehydration activity
depends in part on the amino acids that directly flank the
dehydratable Ser/Thr.7,8 In that light, some substrates appear
unsuitable for wild-type NisB-mediated dehydration.7,8 As a
consequence, the substrate specificity of wild-type dehydratase
NisB can be a limitation for engineering novel lanthipeptides.
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Cell surface display is a powerful method for high-
throughput screening of genetically encoded peptides with
desired properties. Surface display on phage, yeast, and Gram-
positive bacteria has been successfully applied in high-
throughput screening.9−11 Also lanthipeptide display systems
for phage, yeast, and Gram-positive bacteria have been
developed and applied.12 A lanthipeptide cell surface display
system has been devised in Lactococcus lactis NZ9000.13 This
bacterial display system contains a plasmid-encoded linear
lanthipeptide precursor fused to the N-terminus of the L. lactis
surface protease PrtP C-terminal domain and a second plasmid
that encodes the NisBTC enzymes.13
Many cyclic His-Pro-Gln (HPQ) motif-containing peptides
showed up to 3 orders of magnitude higher affinities to
streptavidin than linear HPQ motif-containing peptides.14,15 In
this study, we exploited this high affinity of cyclic streptavidin
ligands compared to linear unmodified streptavidin ligands. We
employed the NisBC enzymes to introduce a thioether cross-
link into a designed strep ligand (SHPQFC), which showed
higher affinity for streptavidin than the linear strep ligand.
Subsequently, a strep ligand was designed where the Ser to be
dehydrated residue is preceded by an Asp residue
(DSHPQFC), which is an unsuitable substrate for NisB. By
lack of dehydration, this peptide would never be subject to
NisC-catalyzed or spontaneous cyclization, thus having lower
affinity to streptavidin than the cyclized variants. For high-
throughput screening of tailored NisB variants from a
genetically encoded NisB library, the unsuitable DSHPQFC
substrate was genetically fused to the display scaffold13 and
coexpressed with a plasmid encoding NisCT and a mutant
NisB library. By use of streptavidin-coupled magnetic beads,
cyclized strep ligand displaying bacteria were selected aiming at
mutant NisB-catalyzed dehydration of DSHPQFC. The results
demonstrate that selection of mutant modification enzymes
from genetically encoded libraries can be based on cell surface
display of mutant-enzyme-modified products.
Figure 1. (a) MALDI-TOF MS data of CS5 before (blue) and after (red) treatment with CDAP and hypothetical structure of CS5. (b) SDS-
Tricine gel of CS5 coexpressed with NisBTC or NisT before (&) and after (#) streptavidin column purification. (c) LC-MS/MS data of CS5(13−
20). The observed fragments demonstrate that the cyclic strep ligand was formed.
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Have Enhanced Capacity to Bind Streptavidin Com-
pared to Linear HPQF Peptides. Previous studies
demonstrated that thioether cross-linked HPQ-containing
cyclic peptides show up to 3 orders of magnitude higher
streptavidin affinities than linear peptides.14,15 In this study, a
cyclic HPQF-containing strep ligand fused to the C-terminus
of nisin fragments was used. To form the cyclic HPQF-
containing strep ligand by lanthipeptide synthetases, a Ser and
a Cys were added at the N- and C-terminus of HPQF,
respectively (SHPQFC). The N-terminus of the designed
SHPQFC strep ligand was engineered at the C-terminus of
nisin, nisin(1−22), or nisin(1−12) (Supplemental Figure S1).
Asn-Lys or Lys was engineered at the C-terminus of the
designed SHPQFC strep ligand, since these residues are
favorable for the NisC-catalyzed cyclization.8 Five peptides
(CS1, CS2, CS3, CS4, and CS5) were designed by following
this setup (Supplemental Figure S1). L. lactis NZ9000 with
pTLR-BTC was transformed with plasmids encoding the
designed peptides, respectively. Following the induction and
purification, the mass of the produced peptides was checked by
MALDI-TOF MS. Of the designed five peptides, only the
construct CS5 was fully dehydrated (Supplemental Figure S2).
The formation of the potentially three NisC-formed thioether
cross-links, two in nisin(1−12) and one in the designed
streptavidin ligand of CS5, was investigated using 1-cyano-4-
dimethylaminopyridinium tetrafluoroborate (CDAP), a com-
pound that reacts with unmodified cysteines in peptides.
CDAP reaction to cysteine results in an increase of 25 Da in
the peptide’s molecular weight.4,16 CDAP treatment was
executed under reducing conditions followed by trypsin
cleavage and LC-MS/MS analysis. Very little 25 Da adduct
was observed for the CS5 main product (Figure 1a), indicating
that no unmodified cysteines were present. This implied that
most thioether cross-links in CS5 were formed, including the
intended thioether cross-link for the strep ligand (Figure 1a).
Subsequently, a trypsin-mediated cleavage demonstrated that
the cyclic strep ligand was correctly formed (Supplemental
Figure S3). Furthermore, LC-MS/MS for CS5(13−20)
confirmed the presence of the designed cyclic strep ligand in
CS5 (Figure 1c). These results proved the CS5 structure
(Figure 1a), a lanthipeptide composed of N-terminal nisin
followed by a cyclic strep ligand. Subsequently, CS5 was
expressed in the presence of only NisT for production of linear
strep ligand. After purification, the streptavidin binding
capacity of cyclic and linear CS5 peptides was investigated
by using a streptavidin column. After elution, the fractions
were analyzed by Tricine-SDS gel (Figure 1b, lanes 3 and 4).
The cyclic strep ligand containing CS5 bound to the
streptavidin column, since a clear band appeared from the
elution fraction of cyclic strep ligand containing CS5 (Figure
1b, lane 3). However, no band was observed from the elution
fraction of linear HPQF-containing CS5 (Figure 1b, lane 4),
indicating that under the used conditions linear HPQF-
containing CS5 had no or too low binding affinity to
streptavidin. These data confirm that the cyclic strep ligand
containing CS5 peptide has significantly higher affinity to
streptavidin than the linear one.
Cyclic HPQF-Containing Peptide Displayed on the
Cell Surface by an Improved Display Scaffold. A previous
study demonstrated a PrtP protease-based cell surface display
system in L. lactis.13 To display the cyclic HPQF strep ligand of
CS5 on the cell surface of L. lactis, the CS5 was genetically
fused to an extension-improved L. lactis display scaffold
described in Materials and Methods (peptides are fused to a
cell wall bound part of PrtP protease via an LPXTG motif). A
human rhinovirus (HRV)-3C protease cleavage site (sequence
LEVLFQGP) was introduced between CS5 and the improved
scaffold (stalk and cell wall spacer, LPxTG domain and TMS
domain) (BD-CS5, Supplemental Figure S1). To investigate
whether the cyclic HPQF strep ligand of CS5 was also formed
within the L. lactis displayed BD-CS5, a streptavidin column
Figure 2. (a) SDS-Tricine gel of BD-CS5 coexpressed with NisBTC or NisT before (&) and after (#) streptavidin column purification. (b)
Structure of BD-CS5 with a cyclic strep ligand. (c) Whole-cell ELISA on L. lactis NZ9000 cells demonstrates that cyclic HPQF is displayed on the
cell surface; each column represents the mean ± SD of three independent experiments; the statistical significance of differences was evaluated by
Pearson r2, ns, p > 0.05; *p < 0.05 vs L. lactis NZ9000 cells (without plasmid).
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binding experiment was performed. Briefly, BD-CS5 was
expressed in the presence of either NisBTC (modified) or
NisT (unmodified). After purification of expressed modified
and unmodified BD-CS5 proteins, their streptavidin binding
capacity was investigated by using a streptavidin column. After
elution, the fractions were investigated by Tricine-SDS gel
(Figure 2a, lanes 3 and 4). After the streptavidin column, the
fraction corresponding to BD-CS5 coexpressed with the
NisBTC enzymes showed a band on the tricine gel (Figure
2a, lane 3). In contrast, the fraction corresponding to BD-CS5
coexpressed with NisT showed no visible band (Figure 2a, lane
4). These results indicated that the thioether cross-link
between Ser and Cys in SHPQFC had been installed by
NisBC (Figure 2b). Subsequently, a whole cell ELISA assay
was performed using horseradish peroxidase (HRP)-conju-
gated streptavidin to investigate whether the cyclic HPQF
strep ligand was displayed on the surface of L. lactis. Figure 2c
clearly shows cell surface display for induced L. lactis with
plasmids pTLR-BTC and pBD-CS5, whereas only background
level was observed in uninduced and NisBC lacking L. lactis.
Together, these results clearly demonstrate that cyclic HPQF
strep ligand was successfully formed and displayed on the
surface of L. lactis.
Directly Serine-Flanking Amino Acids Affect NisB-
Catalyzed Dehydration of SHPQFC. Rink et al.8 demon-
strated that some amino acid residues directly flanking Ser or
Thr can inhibit or even abolish the dehydration of these Ser
and Thr residues by NisB.8 A subsequent study demonstrated
that essentially all hydrophobic flanking amino acids favor
dehydration of Ser and Thr, whereas hydrophilic amino acids,
Asp, Glu, and Arg, and also Gly disfavor hydration.7 Based on
these studies,7,8 three NisB-unfavorable (Asp, Glu, Arg) and
four favorable (Ala, His, Met, Trp) amino acid codons were
genetically inserted in front of SHPQFC of CS5 (CS5D, CS5E,
CS5H, CS5M, CS5R, CS5W, and CS5A, Supplemental Figure
S1). Plasmids encoding the designed peptides were trans-
formed into L. lactis NZ9000 with pTLR-BTC. After the
induction and purification, the mass of the produced peptides
Figure 3. (a) Dehydration of the designed peptides. Green, full dehydration; red, only four dehydrations. (b) Hypothetical structure of CS5D,
which has no cyclic HPQF. (c) BDD construct for selecting NisB variants that can dehydrate Ser when preceded by an Asp residue in a DSHPQFC
sequence.
Figure 4. Schematic diagram of selection mutant NisB with improved dehydration capacity. Cyclic strep ligand has higher affinity to streptavidin
than linear strep ligand, allowing the use of streptavidin-coupled magnetic beads to fish out the bacteria with NisBmut that can dehydrate Ser
preceded by Asp.
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was checked by MALDI-TOF MS. Insertion of hydrophobic
amino acids, Ala, Met, or Trp, or insertion of His resulting in
the sequences ASHPQFC, MSHPQFC, WSHPQFC, or
HSHPQFC allowed full dehydration (Figure 3a, Supplemental
Figure S4). On the other hand, NisB-unfavorable Glu, Asp, and
Arg residues reduced the extent of dehydration (Figure 3a,
Supplemental Figure S4). Moreover, insertion of a NisB-
unfavorable Asp residue before SHPQFC completely abolished
the dehydration of the resulting DSHPQFC (CS5D) (Figure
3a,b, Supplemental Figure S4). Therefore, it would be
interesting to find a NisB variant that can fully dehydrate
CS5D. Hence, CS5D was selected for further studies (Figure
3b). CS5D was fused to the display scaffold (BD-CS5D,
Supplemental Figure S1) and coexpressed with NisBTC
enzymes. After purification, BD-CS5D was applied to a
streptavidin column for testing its binding capability as
described above. BD-CS5D, which contained DSHPQFC,
showed no streptavidin column binding capability under the
conditions used (data not shown), indicating that the Asp
residue also blocked the dehydration of Ser in DSHPQFC
within BD-CS5D. After removal of the his6 tag of pBD-CS5D,
a pBDD vector (Figure 3c) was constructed for selecting NisB
variants that can dehydrate Ser when preceded by an Asp
residue in a DSHPQFC sequence.
Selected NisBS88P/D234N Dehydrates DSHPQFC. High-
throughput selection is a robust approach to improve
properties of enzymes or proteins. To find NisB enzyme
variants with the ability to dehydrate Ser preceded by Asp in
the strep ligand context used here, a full NisB mutant library
was constructed by error-prone PCR, which involved about
100 000 NisB variants according to colony counting and gene
sequencing. After transformation of the NisB library into a
pBDD plasmid-containing (Supplemental Figure S1) L. lactis
NZ9000 strain, streptavidin-coupled magnetic beads were used
in panning rounds to select cyclic strep ligand displaying L.
lactis (Figure 4). After three panning rounds, the cells were
plated on GM17 agar with antibiotics. After overnight growth,
20 colonies were randomly picked, followed by sequencing of
nisB. Strikingly, the NisBS88P/D234N appeared 18 times out of 20
randomly picked colonies (NisBN292K and NisBT115I appeared
in the remaining two colonies). Subsequently, the dehydration
capability of the three obtained NisB variants was evaluated by
dehydration of CS5D and CS5A. The MALDI-TOF MS
showed that fully dehydrated main products of CS5A were
obtained in all three NisB variant containing strains, which
means that the NisB variants obtained still kept the function of
NisBwt (Figure 5b). NisBN292K and NisBT115I showed low-
efficiency dehydration of Ser preceded by Asp (CS5D) (data
not shown). In contrast, the NisBS88P/D234N variant showed
significant improvement in the dehydration of Ser preceded by
Asp (CS5D) and produced a fully dehydrated main product
(Figure 5a). To investigate whether this improvement also
appeared in the displayed proteins, a HRV-3C protease was
used to release the N-terminal part of the displayed proteins.
NisBS88P/D234N almost completely dehydrated the Ser of
SHPQFC preceded by either NisB-favorable Ala or NisB-
unfavorable Asp (Figure 5c,d). These results demonstrate that
a NisB enzyme with tailored substrate specificity was
discovered by selection of a bacterially displayed cyclic
HPQF sequence.
Figure 5. MALDI-TOF MS data of peptides modified by NisBwt (blue) or NisBS88P/D234N (green). (a) CS5D; (b) CS5A; (c) N-terminal part of
BDA, which was released by HRV-3C protease from cell surface; (d) N-terminal part of BDD, which was released by HRV-3C protease from cell
surface; (e) nisinT2D; (f) nisinT2E; (g) nisin(1−22)K12D; (h) nisin(1−22)K12E; (i) nisin(1−22)G14D; (m) nisin(1−22)G14E.
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NisBS88P/D234N Improves the Dehydration of NisBwt
Unfavorable Substrates. In order to investigate the
dehydration capacity of the selected NisBS88P/D234N, six NisBwt
unfavorable substrates were designed and coexpressed with
NisBS88P/D234N and NisTC. MALDI-TOF MS results showed
that NisBS88P/D234N improved the dehydration of all six
designed nisin variants with respect to NisBwt (Figure
5e,f,g,h,i,m, Table 1). Moreover, NisBS88P/D234N showed
capacity to dehydrate nisin comparable to NisBwt (Table 1,
Supplemental Figure S5a,b). Considering that NisBS88P/D234N is
an enzyme with two mutations, single mutant NisBS88P and
NisBD234N were constructed and used to modify both NisBwt
favorable and unfavorable substrates. Both NisBS88P and
NisBD234N improved the dehydration of nisinT2E, nisin(1−
22)K12E, nisin(1−22)G14D, and nisin(1−22)G14E with respect to
NisBwt (Table 1, Supplemental Figures S6g,h and
S7c,d,e,f,g,h). In addition, both NisBS88P and NisBD234N
showed dehydration capacity comparable to NisBwt for nisin
and CS5A (Table 1, Supplemental Figure S5a,c,d). However,
both NisBS88P and NisBD234N showed less dehydration than
NisBS88P/D234N for CS5D, nisin(1−22)K12E, and nisinT2D
(Figure 5a,e, Table 1, Supplemental Figures S6c,d,e,f and
S7a,b). These results demonstrate that, in contrast to NisBwt,
NisBS88P/D234N shows significant dehydration of Ser/Thr that
are flanked by Asp/Glu. Furthermore, NisBS88P/D234N has better
dehydration capacity than the single mutant enzymes NisBS88P
or NisBD234N.
■ DISCUSSION
Although L. lactis cells containing NisB have been frequently
used for the discovery of lanthionine-stabilized and target-
specific therapeutic peptides,13,17−20 unsuitable NisB substrates
constitute a limitation in engineering lanthipeptides.8,21,22 The
overall structure of the dehydratase NisB was revealed by
crystal structure analysis in 2015,6 and some residues of the
dehydratase NisB have been proven to be important for the
dehydration activity.6,23,24 However, to the best of our
knowledge, up to now no LanB variant has been generated
with modulated or tailored substrate specificity. Here, we show
a valuable approach for de novo selection of tailored
intracellular NisB dehydratase by screening of a cell surface
displayed, high-affinity strep ligand that was intracellularly
modified by mutant NisB.
Directed evolution has arguably become the most effective
strategy for improving or altering the activity of enzymes,25−28
but the success of this strategy is dependent on the library size
and the efficiency of the selection method. Focused muta-
genesis and random mutagenesis are commonly used
approaches for gene diversification.25 A focused mutagenesis
approach requires phylogenetic information on enzymes, and
even if the essential data are available, deducing the
determinants of enzyme function at the amino acid level can
be challenging.25 Moreover, the small library size of focused
mutagenesis may be responsible for the low success rate for
selecting enzymes with desired activity. Therefore, in this
study, a random mutagenesis approach was used to construct
the NisB library, and L. lactis containing this library was
subjected to cell surface displayed product screening.
The traditional screening approaches, which are based on
agar plate or microplate assays, would require robotics to
handle such large libraries. In the absence of robust screening
methods, it seems difficult or even impossible to identify
enzyme variants with desired properties.29−31 If screening
approaches are not amenable to automation, only about 1000
to 2000 of the mutants can be screened for desired
properties.26,29 Cell surface display combined with target-
displaying magnetic beads for panning rounds has been widely
used in antibody32,33 and drug34,35 discovery. In this study, a
lanthipeptide L. lactis display system was applied.13 A NisB
dehydratase mutation with the capacity to dehydrate substrates
that could not be dehydrated by wild-type NisB was
successfully discovered (Table 1, Figure 5). These results
raise the hope that the here-used principle can be widely
applied.
In previous cell surface display studies, protein libraries,
which were used for screening protein variants with desired
properties, were usually fused to a display scaffold and
thereafter displayed on the cell surface.15,36−38 Subsequently,
the selections were based on higher target affinity.15,36−38 In
contrast, in our present study, the enzyme library itself was not
displayed on the cell surface, but the corresponding aimed-for
product was (Figure 2c and 4). This constitutes a powerful
strategy for high-throughput selecting of intracellular enzyme
variants with desired properties.
NisB is a glutamyl-tRNAGlu-dependent lantibiotic dehydra-
tase, and the function of each domain has been revealed in
previous studies6 (Figure 6a). The dehydration process of
Table 1. Dehydration of Designed Peptides by Different NisB Mutationsa
observed mass (Da, main product)/dehydrations
peptide predicted mass (Da)/dehydrations NisBwt NisBmut(S88P/D234N) NisBmut(S88P) NisBmut(D234N)
nisin 5688/8 5689/8 5687/8 5687/8 5687/8
CS5D 5477/5 5496/4 5477/5 5495/4 5495/4
CS5A 5433/5 5434/5 5434/5 5432/5 5433/5
nisinT2D 5720/7 5739/6 5723/7 5736/6 5737/6
nisinT2E 5734/7 5747/6 5732/7 5734/7 5732/7
nisin(1−22)K12D 4460/5 4479/4 4479/4 4477/4 4476/4
nisin(1−22)K12E 4474/5 4473/5 4473/5 4472/5 4471/5
nisin(1−22)G14D 4531/5 4548/4 4532/5 4531/5 4530/5
nisin(1−22)G14E 4545/5 4559/4 4542/5 4543/5 4543/5
aNisinT2D, the second amino acid of nisin was changed from Thr to Asp; nisinT2E, the second amino acid of nisin was changed from Thr to Glu;
nisin(1−22)K12D, the 12th amino acid of nisin was changed from Lys to Asp; nisin(1−22)K12E, the 12th amino acid of nisin was changed from Lys
to Glu; nisin(1−22)G14D, the 14th amino acid of nisin was changed from Gly to Asp; nisin(1−22)G14E, the 14th amino acid of nisin was changed
from Gly to Glu. bThe major products with less dehydration than predicted are in italic. The major products with predicted dehydration are in
bold.
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NisB involves glutamyl-tRNAGlu to activate Ser or Thr
residues.6 Therefore, glutamyl-tRNAGlu plays a vital role in
the NisB-catalyzed dehydration of Ser and Thr residues. In the
present study, the NisBS88P/D234N mutation was discovered by
the herein developed method. Both of the mutation points of
NisBS88P/D234N are located in the glutamyl-tRNAGlu binding site
of NisB (Figure 6b). Also the single mutation points of
NisBN292K and NisBT115I are located in the glutamyl-tRNAGlu
binding site of NisB (Figures S8b and S9b). For further
characterization, an amino acid sequence alignment of LanB
protein sequences was performed.39 The results show that all
four mutation positions are nonconserved positions (Figure
S10). Moreover, the mutated amino acid residues of
NisBS88P/D234N and NisBN292K increased the probability value
of the corresponding positions. These results suggest that the
improved substrate tolerance of NisBS88P/D234N is caused by the
mutations in NisB that promote a slightly different and more
productive positioning of the glutamyl-tRNAGlu, allowing a
more efficient transfer of the glutamyl moiety. In addition, a
silightly different positioning of the peptide substrate in the
NisB mutant may also led to a more efficient glutamyl-
tRNAGlu-catalyzed activation of the respective amino acid
residues for dehydration. The findings thus open the way for
exciting follow-up studies aimed at understanding the exact
underlying mechanistic aspects.
In conclusion, our results demonstrate that a tailored NisB
dehydratase was selected from an intrabacterial mutant NisB
library by selecting a bacterial cell surface displayed, high-
affinity NisB-modified strep ligand in panning rounds with
streptavidin-coupled magnetic beads. These results open a new
window for high-throughput selection of lanthipeptide
synthetases with modulated capacity to modify specific
substrate peptides.
■ MATERIALS AND METHODS
Microbial Strains Used and Growth Conditions.
Strains and plasmids used in this study are listed in
Supplemental Table S1. E. coli XL-10 Gold ultracompetent
cells were used for construction of the NisB library. E. coli
stains were grown in LB medium or LB medium solidified with
1% (w/v) agar at 37 °C. For plasmid selection, 250 μg/mL
erythromycin (Sigma) was added.
L. lactis NZ9000 was used for plasmid construction, plasmid
maintenance, and protein expression. L. lactis was grown at 30
°C in M17 broth (Oxoid) or M17 broth solidified with 1% (w/
v) agar, containing 0.5% (w/v) glucose (GM17) when
necessary, supplemented with chloramphenicol (5 μg/mL)
or erythromycin (5 μg/mL) for plasmid selection. For protein
expression, stationary-phase cultures were inoculated (20-fold
diluted) on GM17 broth and induced with nisin (5 ng/mL) at
an optical density at 600 nm (OD600) of about 0.4.
Molecular Biology Techniques. Lists of oligonucleotide
primers used for PCR, cloning, and sequencing in this study
are provided in Supplemental Tables S2 and S3, and all the
oligonucleotide primers were purchased from Biolegio B.V.
(Nijmegen, The Netherlands). Constructs coding for mutants
of peptides or display proteins were made by amplifying
template plasmid using a phosphorylated downstream sense
(or upstream antisense) primer and an upstream antisense (or
downstream sense) primer with a peptide-encoding tail. The
DNA amplification was carried out using phusion DNA
polymerase (Thermo Fisher Scientific, Waltham, MA). Self-
ligation of the resulting plasmid encoding linear leader peptide
was carried out with T4 DNA ligase (Thermo Fisher Scientific,
Waltham, MA). The electrotransformation of L. lactis was
carried out as previously described using a Bio-Rad gene pulser
(Bio-Rad, Richmond, CA).40 Correctness of all genetic
constructs was verified by sequencing. The peptide mutations
were verified by sequencing using the forward primer PS1 or
the reverse primer PS2, and the NisB variants were verified by
sequencing using primers PS3−PS8.
Plasmid Cloning for Lanthipeptide Surface Display.
PrtP protease C-terminal domain (1586−1962 aa), here
designated stalk and anchor, was amplified from L. lactis
SK11 cells using primers Pbd1 and Pbd2. A DNA fragment
encoding the NisA promoter, NisA leader peptide, and CS5
core peptide was amplified from the pCS5 plasmid with
primers Pbd3 and Pbd4. Part of the structure gene of pCS5
encoding an NdeI cleavage site was amplified from pCS5 with
primers Pbd5 and Pbd6. The different amplification products
were spin column-purified, and joined by PCR fusion. The full-
length amplification product was amplified using oligomers
Pbd3 and Pbd6. After spin column purification, the full-length
amplification product, and plasmid pCS5 were digested with
BglII and NdeI. After collection of the digested fragments, T4
ligase was used to ligate the two fragments and thereafter
electroporated to L. lactis NZ9000. The resulting plasmid was
designated pBD-CS5 and encoded the NisA promoter, NisA
Figure 6. (a) Overall structure of the NisB dehydratase and the functions of each domain.6 (b) Glutamyl-tRNAGlu binding site. Amino acids are
shown in green that are known to be important for glutamyl-tRNAGlu binding; mutation points of NisBS88P/D234N are shown in red.
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leader peptide, pCS5 core peptide, stalk, and cell wall anchor
domain.
NisB Library Synthesis. To construct a NisB library, an
error-prone PCR was performed by using the GeneMorph II
Random Mutagenesis Kit (Agilent). Plasmid backbone of
pTLR-BTC41 was amplified by using high fidelity PCR with
primers Ptlr1 and Ptlr2. The nisB gene was amplified by error-
prone PCR with primers Ptlr3 and Ptlr4. The error-prone PCR
of the nisB gene was performed using 50, 250, and 750 ng of
template to obtain a low, medium, and high rate of mutation.
In order to remove the template plasmids, a DpnI (FastDigest,
Thermo) digestion was performed. After that, the error-prone
PCR products were mixed at the same concentration (50 ng)
that was used as template for a second generation of PCR
amplification by using the enzyme pfu×7.42 For the ligation,
various concentrations of insert ranging from 1 to 6 with
respect to the backbone (200 ng) were performed. After
dialysis, the ligation mixes were transformed into E. coli XL-10
Gold chemo-competent cells. After growth overnight at 37 °C,
the efficiency of the transformation was calculated. Cells were
harvested from the plates, and NisB library plasmids were
isolated by using the NucleoSpin Plasmid EasyPure kit
(Macherey-Nagel, Düren, Germany). Gene sequencing verified
that the NisB library was obtained as expected.
Expression and Purification of His6-Tagged Peptides
and Proteins. L. lactis NZ9000 cells containing pTLR-BTC
for expression of the NisBTC enzymes were electroporated
with His6-protein plasmids (50 ng), plated on M17 agar plates
containing 0.5% (w/v) glucose supplemented with chloram-
phenicol (5 μg/mL) and erythromycin (5 μg/mL), and grown
at 30 °C for 20−24 h. A single colony was used to inoculate 50
mL of GM17 supplemented with chloramphenicol (5 μg/mL)
and erythromycin (5 μg/mL) (GM17EmCm), and the culture
was grown for 15−18 h at 30 °C. After that, the culture was
used to inoculate 1 L (20-fold dilution) of GM17EmCm.
Cultures were grown at 30 °C to an OD600 of 0.4. Protein
expression was induced by the addition of nisin to a final
concentration of 5 ng/mL, and cultures were grown overnight
at 30 °C.
Purification of Secreted Peptides. After centrifugation at
15 000 × g for 15 min, supernatants were collected. The pH of
supernatants was adjusted to 7.4, and then supernatants were
filtered through a 0.45 μm membrane. Supernatants were
applied to a HisTrap Excel column (GE Healthcare)
equilibrated with 50 mM NaH2PO4, 300 mM NaCl, and 10
mM imidazole, pH 8.0. The flow-through was discarded, and
the column was subsequently washed with 16 column volumes
(CV) of wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20
mM imidazole, pH 8.0). The peptide was eluted with 15 CV of
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM
imidazole, pH 8.0). The eluted peptide was then applied to a
SIGMA-Aldrich C18 silica gel spherically equilibrated first with
8 CV of MeCN containing 0.1% trifluoroacetic acid followed
by 8 CV of 5% aq. MeCN containing 0.1% trifluoroacetic acid.
The column was washed with 8 CV of 5% aq. MeCN
containing 0.1% trifluoroacetic acid to remove the salts.
Peptide was eluted from the column using up to 8 CV of 50%
aq. MeCN containing 0.1% trifluoroacetic acid. Fractions
containing the eluted peptide were freeze-dried, and the
peptide was subsequently dissolved in PBS containing an
appropriate amount of NisP and incubated at 37 °C for 2 h to
cleave off the leader peptide. The insoluble material was
removed by filtration through a 0.2 μm filter, and the
supernatant was purified on an Agilent 1260 Infinity HPLC
system with a Phenomenex Aeris C18 column (250 mm × 4.6
mm, 3.6 μm particle size, 100 Å pore size). Acetonitrile was
used as the mobile phase, and a gradient of 20−30% aq.
MeCN over 35 min at 1 mL/min was used for separation.
Peptides eluted at 27−29% MeCN.
Purification of Displayed Bacterial Proteins. After
centrifugation at 15 000 × g for 15 min, cells were collected.
After treatment with lysis buffer (50 mM Tris-HCl, 2 mM
EDTA, 100 mM NaCl, 0.5% Triton X-100, pH 8.5) containing
10 mg/mL lysozyme at 37 °C for 1 h, cell homogenates were
sonicated for 12 min in total. The insoluble material was
subsequently removed by centrifugation at 10 000 × g for 20
min, and supernatants were filtered through a 0.45 μm
membrane. The supernatants were applied to a HisTrap Fast
Flow column (GE Healthcare) equilibrated with 50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0. The
flow-through was discarded, and the column was subsequently
washed with 16 CV of wash buffer (50 mM NaH2PO4, 300
mM NaCl, 20 mM imidazole, pH 8.0). The proteins were
eluted with 15 CV of elution buffer (50 mM NaH2PO4, 300
mM NaCl, 250 mM imidazole, pH 8.0). After filtration
through a 0.2 μm membrane, the eluted proteins were purified
on an Agilent 1260 Infinity HPLC system with a Phenomenex
Aeris C18 column (250 mm × 4.6 mm, 3.6 μm particle size,
100 Å pore size). Acetonitrile was used as the mobile phase,
and a gradient of 20−70% aq. MeCN over 60 min at 1 mL/
min was used for separation. Proteins were eluted at 59−61%
MeCN.
Whole-Cell ELISA for Detection of Surface-Displayed
Cyclic HPQF. L. lactis NZ9000 cells containing plasmids pBD-
CS5 and pTLR-BTC/pTLR-T and L. lactis NZ9000 cells were
grown with or without nisin (5 ng/mL) for induction of
modification enzymes and protein expression. After produc-
tion, cells were collected by centrifugation, washed three times
with MES buffer (0.1 M, pH 7.4) plus 20 mM Cacl2 (MES-
Ca), and then resuspended to an OD600 of 20. Aliquots of
OD600 = 3.0 from these cell suspensions were incubated with a
4000-fold diluted horseradish peroxidase (HRP)-conjugated
streptavidin solution (Thermo Fisher Scientific, Waltham,
MA) in a final volume of 1 mL of MES-Ca plus 0.2% Tween 20
and 1% BSA at room temperature for 1 h under rotation. After
three washes with MES-Ca-T-BSA, the displayed cyclic HPQF
was visualized by the addition of 1 mL of 1-Step ABTS
horseradish peroxidase substrate solution (Thermo Fisher
Scientific, Waltham, MA). The absorbance was determined at
410 nm after a suitable time period, which is a measure for the
displayed cyclic HPQF.
Mass Spectrometry. One microliter of sample was spotted
and dried on the target. Subsequently, 0.7 μL of matrix
solution (5 mg/mL α-cyano-4-hydroxycinnamic acid from
Sigma-Aldrich dissolved in 50% acetonitrile containing 0.1%
trifluoroacetic acid) was spotted on top of the sample. Matrix-
assisted laser desorption ionization-time-of-flight (MALDI-
TOF) mass spectrometer analysis was performed using a 4800
Plus MALDI TOF/TOF Analyzer (Applied Biosystems) in the
linear-positive mode.
Evaluation of (Methyl)lanthionine Formation. After
the freeze-dried samples were dissolved in 18 μL of 0.5 M
HCL (pH = 3), the samples were treated with 2 μL of 100 mg/
mL tris[2-carboxyethyl]phosphine in 0.5 M HCL (pH = 3) for
30 min at room temperature. Subsequently, 4 μL of 100 mg/
mL 1-cyano-4-dimethylaminopyridinium tetrafluoroborate
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(CDAP) in 0.5 M HCL (pH = 3) was added to the samples.
After incubation at room temperature for 2 h, the samples were
desalted with a C-18 ZipTip (Millipore) and analyzed by
MALDI-TOF MS.43
LC-MS/MS. To gain insight into the lanthionine bridging
pattern, we performed MS/MS. LC-MS was performed using a
Q-Exactive mass spectrometer fitted with an Ultimate 3000
UPLC, an ACQUITY BEH C18 column (2.1 mm × 50 mm,
1.7 μm particle size, 200 Å; Waters), a HESI ion source, and an
Orbitrap detector. A gradient of 5−90% MeCN with 0.1%
formic acid (v/v) at a flow rate of 0.35 mL/min over 60 min
was used. MS/MS was performed in a separate run in PRM
mode selecting the doubly and triply charged ion of the
compound of interest.
Library Screening by Streptavidin-Coupled Magnetic
Bead Assisted Cell Sorting. An aliquot of the NisB library
transformed cells (∼5 × 1010 cells) was inoculated in 50 mL of
GM17EmCm. The culture was grown at 30 °C until an OD600
of about 0.4. At this point, protein and enzyme production was
induced by adding nisin at a final concentration of 5 ng/mL.
Incubation was continued overnight. Library-containing cells
were collected by centrifugation, washed three times with 0.1
M MES-Ca, and resuspended in 2 mL of MES-Ca-T-BSA. To
reduce the number of nonspecifically binding peptides from
the initial library, a 1 mL of library cell suspension was
incubated for 30 min at room temperature with 200 μL of
biotin-saturated streptavidin-coupled magnetic beads (Dyna-
beads and MyOne Streptavidin T1; Invitrogen). The unbound
cells in the supernatant were collected and resuspended in 1
mL of MES-Ca-T-BSA. For the first round of selection, 200 μL
of streptavidin-coupled magnetic beads was added and
incubated under rotation at room temperature for 1 h.
Streptavidin-binding cells were collected by magnetic-bead
assisted cell sorting (MACS), washed 3 times with MES-Ca-T-
BSA, resuspended in 50 mL of GM17EmCm, grown overnight
at 30 °C, and used to produce cells for the next round of
selection. Two additional selection rounds were performed.
After three rounds of MACS, the cells were plated, and
individual clones were picked for sequencing analysis.
Protease Induced Removal of Displayed Peptides
from the Cell Surface and Peptide Purification. L. lactis
surface display vectors pBDA and pBDD were used to compare
the dehydration ability of selected NisB mutation and wild-
type NisB. The produced proteins containing the HRV 3C
protease recognition sequence (PreScission protease; GE
Healthcare) to release the N-terminal part of proteins from
the L. lactis cell surface. L. lactis NZ9000 cells displaying BDA
or BDD was subjected to 16% trichloroacetic acid (TCA) for 1
h on ice. Cells were washed three times with 10 mL of acetone,
dried in a Speed Vac, and washed three times with PBS. The
cells were resuspended in 5 mL of PreScission protease
cleavage buffer (GE Healthcare) containing 200 U of
PreScission protease (GE Healthcare) and incubated at 4 °C
for 48 h under rotation. After protease digestion, the
supernatant was collected, and the N-terminal parts of the
BDA and BDD peptides were purified by HPLC, and
subsequently mass spectrometry was performed.
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